How Robots Are Introducing A New Dimension To Healthcare Service Delivery
Pharma News and Updates for Akero Chiesi Pfizer
AstraZeneca’s Danicopan Trial; CHMP R...

AstraZeneca’s Danicopan Shows Positive Results in Phase III Trial Danicopan, an oral Factor D inhibitor dev...

Latest MedTech News for Olympus and Aerin
Aerin Medical’s RhinAer Stylus; CE Ma...

Johnson & Johnson Vision Launches New Contact Lens Innovation ACUVUE® OASYS MAX 1-Day for Meeting the N...

Pharma News for Azurity, Sobi, and Sanofi
AstraZeneca’s Imfinzi for Biliary Tra...

FDA Approves AstraZeneca’s Imfinzi for Biliary Tract Cancer Imfinzi, a checkpoint inhibitor developed by As...

primary-sclerosing-cholangitis-treatment-landscape
Novel Insights of Primary Sclerosing Cholangitis Treatment Market

There are a few major unmet needs in the primary sclerosing cholangitis (PSC) treatment market, which include a lack of effective therapies, proven surveillance strategies, tools for early detecti...


MedTech News Updates for Renovia and Zsquare
Zsquare ENT-Flex Rhinolaryngoscope Receives FDA Clearance; ClearMind Biomedical’s Completio...

Zsquare ENT-Flex™ Rhinolaryngoscope, the First High-Performance Single-Use ENT Endoscope of Zsquare received FDA Clearance On July 06, 2022, Zsquare, one of the leading developers of hig...


Biogen terminates ALS Pact with Karyopharm; AbbVie’s Immunological Drug Skyrizi; NICE Backs Astel...

Biogen terminates USD 217 Million ALS Pact with Karyopharm Biogen has backed out of the four-year-old partnership with Karyopharm on a drug candidate for the neurological disease amyotrophic la...


Pharma News and Updates for BMS, Mirati, Roche, Dermavant, Merck
Bristol-Myers Squibb’s Opdivo Approval; Mirati’s KRAS-inhibitor Adagrasib; J&J and Legend Bi...

Bristol-Myers Squibb’s Opdivo Gets FDA Approval for Esophageal Cancer The FDA has approved two combination drug regimens based on Bristol-Myers Squibb’s PD-1 inhibitor Opdivo for previously unt...


Pharma News For Sanofi, Bayer, Innoviva
PTC Therapeutics’ Gene Therapy Upstaza; Sanofi and Regeneron’s Dupixent; Bayer CAR-T Collaboratio...

EU Recommends Approval for PTC Therapeutics’ Gene Therapy Upstaza Upstaza, a gene therapy developed by PTC Therapeutics for patients with the genetic condition AADC deficiency, has been recomme...


Smart Pill - Benefits, Challenges, Applications, Key Companies, Future Growth
Evaluating the Major Developments in the Smart Pills Market

As our medical demands rise, so does the technology that distributes our medications. With innovative phone apps, alarms, smart packaging, and smart pills, there is no excuse to miss a dosage or f...


TLR 7 and 8 Agonist
Toll-like receptors (TLR)...

Toll-like receptors (TLR) 7 and 8 are functionally localized to endosomes and recognize specific RNA.....

Gene Therapies Whitepaper
Gene Therapies

Gene therapies are regarded as one of the potential revolution in the Pharmaceutical field and Healt.....

Toll-like Receptors Agonist
Toll-like Receptors Agoni...

Toll-like Receptors (TLRs) are a type of pattern recognition receptor (PRR) that recognizes pathogen.....

Editor's Pick
Which Pipeline Therapy Has The Potential To Revolutionize The Dystrophic Epid...

Dystrophic epidermolysis bullosa (DEB) is a common skin disease with a chronic history ...

Can FcRn Antagonists Be The Game-Changer in the Generalized Myasthenia Gravis...

Though a rare disease, generalized myasthenia gravis (gMG) still affects around 60,000 ...

Exploring Potential New Avenues for Bronchopulmonary Dysplasia Treatment

Bronchopulmonary Dysplasia is the most common long-term respiratory morbidity of low-we...

A Market Space Beyond Lucentis and Eylea for Retinal Vein Occlusion Treatment

Competitive inroads by Regeneron’s Eylea in the retinal vein occlusion treatment landsc...

NexoBrid and its Awaiting US Approval

A Burn takes place when the skin comes into contact with a heat source. Burns can occur...